Table 2.
IR analyses of long bones of mutant and transgenic mice
| Animal model | Finding relative to WT | Reference |
|---|---|---|
| Type X collagen transgenic | No bone or cartilage phenotype | [25] |
| Osteocalcin KO | Cortical bone increased mineral content, decreased crystal size | [26] |
| Matrix glia protein KO | Trabecular mineral content increased, crystal size increased | [27] |
| Biglycan KO | Cortical & Trabecular bone—decreased mineral content, increased crystal size | [28] |
| Osteopontin KO | Increased mineral content, increased crystal size | [29] |
| Osteonectin KO | Increased mineral content, increased crystal size | [30] |
| Dentin matrix protein 1 KO | Decreased mineral content, increased crystal size | [31] |
| Tissue non-specific alkaline phosphatase KO | Decreased mineral content | [12,13] |
| IGF-binding protein 5, TG | Lower mineral content—no change in crystal size | [32] |
| Vitamin D receptor TG | No change in mineral properties | [33] |
| TGF-beta KO | Decreased mineral content, decreased crystal size | [34] |